Serina Therapeutics, Inc.SERNYSE
Loading
Net Margin Over TimeContracting
Percentile Rank22
Studio
Year-over-Year Change

Net income as a percentage of revenue

Percentile
P22
Within normal range
vs 2Y Ago
-95.9x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM-16022.41%+19.5%
2024-19894.64%-12005.1%
2023167.11%+131.2%
2022-536.42%-1189.1%
2021-41.61%+99.8%
2020-20120.37%-2760.6%
2019-703.36%-30.9%
2018-537.39%-14.7%
2017-468.66%+49.6%
2016-929.89%-